Results 201 to 210 of about 369,066 (292)

Current Clinical Utility of Gene Expression Panels in Primary Cutaneous Melanoma. [PDF]

open access: yesCancers (Basel)
Garza TL   +8 more
europepmc   +1 more source

Robustness of a neural network approved for skin cancer diagnosis against variations in sequential images

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background: Convolutional neural networks (CNN) for skin cancer classification have shown results comparable to dermatologists but are vulnerable to minor image transformations. We investigated the robustness of a MDR class‐IIa certified CNN when classifying sequential images of identical lesions.
Alicia Zimmermann   +7 more
wiley   +1 more source

Dermoscopy of Cutaneous Melanoma Metastases: A Comprehensive Literature Review. [PDF]

open access: yesDiagnostics (Basel)
D'Onghia M   +11 more
europepmc   +1 more source

Study Protocol to Characterize Symptom Experience During Immune Checkpoint Inhibitor Therapy for Cutaneous Melanoma. [PDF]

open access: yesNurs Res
Harris CS   +9 more
europepmc   +1 more source

Improvement of overall survival in patients with cutaneous melanoma at a tertiary care center in Germany from 2001 to 2020

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and objectives Systemic treatment of cutaneous melanoma has changed since 2011, with clinical studies demonstrating improved outcomes. This analysis evaluated whether this improvement is evident in a real‐world cohort, focusing on overall survival (OS) and relapse‐free survival (RFS).
Lena Nanz   +7 more
wiley   +1 more source

Cutaneous Melanoma in the Context of Aging. [PDF]

open access: yesMedicina (Kaunas)
Neagu M, Constantin C, Zurac S.
europepmc   +1 more source

A guide to transcriptional cyclin‐dependent kinases in cancer

open access: yesThe FEBS Journal, EarlyView.
Transcriptional cyclin‐dependent‐kinases (tCDKs) facilitate gene expression by promoting RNA polymerase II (RNAPII) progression through discrete phases of the transcription cycle. Aberrant tCDK activity is detectable in different human cancers, thereby contributing to de‐regulated gene expression programs that drive oncogenic phenotypes.
Jennifer R. Devlin   +2 more
wiley   +1 more source

Preclinical Evaluation of Labetalol for Cutaneous Melanoma Drug Repurposing: Cytotoxic Activity in A375 Cells and Mitochondria-Associated Apoptotic Signaling. [PDF]

open access: yesMedicina (Kaunas)
Dahma R   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy